Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 3
2005 8
2006 2
2007 3
2008 7
2009 4
2010 7
2011 8
2012 6
2013 4
2014 2
2015 2
2016 10
2017 2
2018 11
2019 11
2020 7
2021 11
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: nilsson uj. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A, Ruiz R, Sanchez-Varo R, García-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennström M, Vilalta A, Allendorf D, Davila JC, Stegmayr J, Jiménez S, Roca-Ceballos MA, Navarro-Garrido V, Swanberg M, Hsieh CL, Real LM, Englund E, Linse S, Leffler H, Nilsson UJ, Brown GC, Gutierrez A, Vitorica J, Venero JL, Deierborg T. Boza-Serrano A, et al. Among authors: nilsson uj. Acta Neuropathol. 2019 Aug;138(2):251-273. doi: 10.1007/s00401-019-02013-z. Epub 2019 Apr 20. Acta Neuropathol. 2019. PMID: 31006066 Free PMC article.
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T. Mackinnon AC, et al. Among authors: nilsson uj. Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46. doi: 10.1164/rccm.201106-0965OC. Epub 2011 Nov 17. Am J Respir Crit Care Med. 2012. PMID: 22095546 Free PMC article.
Synthesis of 3-azido-3-deoxy-beta-D-galactopyranosides.
Oberg CT, Noresson AL, Delaine T, Larumbe A, Tejler J, von Wachenfeldt H, Nilsson UJ. Oberg CT, et al. Among authors: nilsson uj. Carbohydr Res. 2009 Jul 27;344(11):1282-4. doi: 10.1016/j.carres.2009.05.005. Epub 2009 May 9. Carbohydr Res. 2009. PMID: 19505681
Inhibition of galectins with small molecules.
Oberg CT, Leffler H, Nilsson UJ. Oberg CT, et al. Among authors: nilsson uj. Chimia (Aarau). 2011;65(1-2):18-23. doi: 10.2533/chimia.2011.18. Chimia (Aarau). 2011. PMID: 21469439 Free article. Review.
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside.
Girardi B, Manna M, Van Klaveren S, Tomašič T, Jakopin Ž, Leffler H, Nilsson UJ, Ricklin D, Mravljak J, Schwardt O, Anderluh M. Girardi B, et al. Among authors: nilsson uj. ChemMedChem. 2022 Feb 4;17(3):e202100514. doi: 10.1002/cmdc.202100514. Epub 2021 Oct 6. ChemMedChem. 2022. PMID: 34613662
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.
Zetterberg FR, MacKinnon A, Brimert T, Gravelle L, Johnsson RE, Kahl-Knutson B, Leffler H, Nilsson UJ, Pedersen A, Peterson K, Roper JA, Schambye H, Slack RJ, Tantawi S. Zetterberg FR, et al. Among authors: nilsson uj. J Med Chem. 2022 Oct 13;65(19):12626-12638. doi: 10.1021/acs.jmedchem.2c00660. Epub 2022 Sep 26. J Med Chem. 2022. PMID: 36154172 Free PMC article.
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation.
Humphries DC, Mills R, Boz C, McHugh BJ, Hirani N, Rossi AG, Pedersen A, Schambye HT, Slack RJ, Leffler H, Nilsson UJ, Wang W, Sethi T, Mackinnon AC. Humphries DC, et al. Among authors: nilsson uj. Front Pharmacol. 2022 Aug 8;13:949264. doi: 10.3389/fphar.2022.949264. eCollection 2022. Front Pharmacol. 2022. PMID: 36003515 Free PMC article.
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A, Ruiz R, Sanchez-Varo R, García-Revilla J, Yang Y, Jimenez-Ferrer I, Paulus A, Wennström M, Vilalta A, Allendorf D, Davila JC, Stegmayr J, Jiménez S, Roca-Ceballos MA, Navarro-Garrido V, Swanberg M, Hsieh CL, Real LM, Englund E, Linse S, Leffler H, Nilsson UJ, Brown GC, Gutierrez A, Vitorica J, Venero JL, Deierborg T. Boza-Serrano A, et al. Among authors: nilsson uj. Acta Neuropathol. 2023 Apr;145(4):509-510. doi: 10.1007/s00401-023-02549-1. Acta Neuropathol. 2023. PMID: 36790609 Free PMC article. No abstract available.
Extracellular and intracellular small-molecule galectin-3 inhibitors.
Stegmayr J, Zetterberg F, Carlsson MC, Huang X, Sharma G, Kahl-Knutson B, Schambye H, Nilsson UJ, Oredsson S, Leffler H. Stegmayr J, et al. Among authors: nilsson uj. Sci Rep. 2019 Feb 18;9(1):2186. doi: 10.1038/s41598-019-38497-8. Sci Rep. 2019. PMID: 30778105 Free PMC article.
131 results